Overview

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mirabegron